CAS: 1346705-53-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | DHODH-IN-23 REF: IN-DA0294HNCAS: 1346705-53-0 | 98% | To inquire | Wed 16 Apr 25 |
 | DHODH-IN-23 REF: 54-BUP06547CAS: 1346705-53-0 | 98.09% | 263.00 €~1,199.00 € | Thu 17 Apr 25 |
 | DHODH-IN-23 REF: TM-T67875CAS: 1346705-53-0 | 98.1% | To inquire | Thu 17 Apr 25 |
Ref: IN-DA0294HN
| 25mg | 590.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP06547
| 25mg | 263.00 € | ||
| 50mg | 394.00 € | ||
| 100mg | 560.00 € | ||
| 500mg | 1,199.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025
DHODH-IN-23
CAS:1346705-53-0
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research.
Formula:
C24H21ClFNO4
Purity:
98.1%
Color and Shape:
Liquid
Molecular weight:
441.88
Ref: TM-T67875
| 5mg | 52.00 € | ||
| 10mg | 84.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 375.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 17 Apr 2025
